News | August 02, 2024
Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Accelerating sustainability in Indian pharma industry
Launch of 20 new medicines expected by 2030
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
AMI to become part of Enpro’s Sealing Technologies Segment
Receives registration of Valganciclovir powder for oral solution in Germany
Evinova will operate as a separate health-tech business within AstraZeneca
Subscribe To Our Newsletter & Stay Updated
